Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.
Delivering cancer drugs directly to tumors is difficult. Scientists are working on new approaches to overcome the natural limitations of drugs, including loading them into nanoparticles.
“The drug is packaged into a lipid ball significantly smaller than the width of a hair to make it soluble in the blood stream and prevent negative side effects. The drug-containing nanoparticle ball then travels in the bloodstream to the tumor, where it accumulates and the drug is released in the tumor to kill the cancer cells,” said Gavin Robertson, professor of pharmacology, pathology, dermatology, and surgery and director of the Penn State Hershey Melanoma Center.
In previous research, Robertson discovered the cancer-fighting characteristics of leelamine, a substance derived from pine bark. But leelamine cannot be given by mouth because of poor uptake in the gastrointestinal tract or be injected intravenously because it causes damage to red blood cells.
To address this issue, Robertson and his team developed a new nanoliposome that loads leelamine, called Nanolipolee-007. Nanolipolee-007 can be injected intravenously without causing damage to red blood cells. It then accumulates in tumors because of its small size where it releases the drug to kill the cancer cells.
Leelamine is the first of a new unique class of drugs that inhibits cholesterol movement around a cancer cell to shut down signals needed for cancer cell survival. As a result, protein pathways like the PI3K, MAPK and STAT3 that are highly active and help cancer cells multiply and spread, are turned off and the cancer cells die. Since normal cells are not addicted to the high levels of activity of these pathways that occur in cancer cells, the drug has a minor effect on them.
“This nanoparticle moves leelamine one step closer to the clinic,” Robertson said. “We now have a drug that has the potential to be given to humans that could not be done before.”
The researchers showed the results of Nanolipolee-007 on cells growing in culture dishes and in tumors growing in mice following intravenous injection. Leelamine inhibited tumor development in mice with no detectable side effects.
The Latest on: Drug-containing nanoparticle
via Google News
The Latest on: Drug-containing nanoparticle
- Drug-Carrying Nanoparticles Could Be The Future Of Cancer Treatmenton May 25, 2018 at 8:01 am
tiny drug-containing capsules only a little more than 100 nanometers big. These nanoparticles deliver treatment straight to the tumor, killing the cancerous cells and preventing regrowth.
- Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapyon October 15, 2017 at 5:00 pm
1D). We have developed an innovative core-shell nanoparticle system for the treatment of lung cancers by effectively combining chemo- and radio-therapy. This nanoparticle system has several ...
- Skin patch dissolves 'love handles' in miceon September 15, 2017 at 6:03 am
Each mouse was given two patches--one loaded with drug-containing nanoparticles and another without drug--that were placed on either side of the lower abdomen. New patches were applied every three ...
- A mechanical trigger for toxic tumor therapyon June 15, 2017 at 8:39 am
The key to this new method is the creation of nanoparticle aggregates (NPAs), which are tiny structures consisting of drug-containing ... 15). A mechanical trigger for toxic tumor therapy ...
- A mechanical trigger for toxic tumour therapyon June 15, 2017 at 3:26 am
Cells in nearly any part of the body can become cancerous and transform into tumours. Some, like skin cancer, are relatively accessible to treatment via surgery or radiation, which minimises ...
- A mechanical trigger for toxic tumor therapyon June 14, 2017 at 9:02 pm
The key to this new method is the creation of nanoparticle aggregates (NPAs), which are tiny structures consisting of drug-containing nanoparticles surrounded by a supportive matrix, akin to the ...
- The future of VR in medicine: 3D brain surgery, designer chemo drugs and anatomy toolson November 11, 2016 at 12:14 am
This is where VR could save the day. “A VR simulation of a drug-containing nanoparticle and the surface of the targeted cancer cells allows the researcher to better understand and assess the int ...
- Black Female Physicist, Tuskegee Professor Awarded $1.1 Million Grant To Fight Canceron January 7, 2016 at 2:27 pm
The way the technology works is that an FDA-approved drug containing nanoparticles is injected into a cancer patient and causes the patient’s tumor to fluoresce (glow) under imaging equipment.
- BIND Therapeutics Co-Founder Publishes Nanotechnology Article in the Journal of the American Medical Associationon January 22, 2015 at 5:08 am
In the article, titled “Science and Medicine: Nanotechnology,” Dr. Langer provides his vision of therapeutic improvements that may be possible with drug-containing nanoparticles, including the ...
- Nanoparticle-based invention moves new cancer drugs closer to clinical testingon October 22, 2014 at 5:00 pm
The drug-containing nanoparticle ball then travels in the bloodstream to the tumor, where it accumulates and the drug is released in the tumor to kill the cancer cells," said Gavin Robertson ...
via Bing News